Julie Steenhuysen is a health and science correspondent for Reuters, specializing in medical and scientific journalism. She is known for her detailed and accurate reporting on public health issues, medical research, and scientific developments. Steenhuysen covers a wide range of topics, including infectious diseases, vaccine development, and healthcare policy. Her work often involves explaining complex scientific information in a clear and accessible manner, making her a respected figure in health journalism. She has contributed to discussions on major health events such as the COVID-19 pandemic, reporting on virus variants, vaccine trials, and related healthcare challenges worldwide. Steenhuysen has also written for prominent publications, including The Saturday Evening Post, and has contributed to the World Economic Forum’s agenda, reflecting her engagement with global health topics. Her reporting is valued for its factual accuracy and relevance, providing insights that inform both the public and professionals in the health sector. Currently active, Julie Steenhuysen remains a significant voice in health and science communication, frequently addressing emerging health crises and scientific breakthroughs. Her recent coverage includes updates on COVID-19 variants, vaccine efficacy, and innovative medical treatments, maintaining her role as a trusted source in the evolving landscape of health journalism.
#vaccines #public health #anti-vaccine movement
The inclusion of anti-vaccine activists in a panel meant to advise the government raises concerns about the credibility and objectivity of the group, and could have dangerous consequences for public health.
The unexpected decision to fire members of the (CDC) Advisory Committee on Vaccines has raised concerns about the future of vaccine safety and research in the United States. Learn more about the controversy and its potential impact on public health.